Gilead Sciences, Inc.
GILD · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $29.4B | $28.8B | +2.4% |
| Operating income | $10.0B | $1.66B | +503% |
| Net income | $8.51B | $480M | +1,673% |
Latest quarter: Q3 2026
Form 10-Q · Three months ended Sep 30, 2026 · filed Oct 30, 2026
| $ | Q3 2026 | Year earlier | Change |
|---|---|---|---|
| Revenue | $8.30B | $7.77B | +6.8% |
| Operating income | $3.46B | $3.33B | +4.1% |
| Net income | $2.43B | $3.05B | −20.4% |
Q3 2026 dashboardQ3 2026 infographic
Questions
- What was Gilead's revenue in FY2025?
- $29.4B in FY2025 (Fiscal year ended Dec 31, 2025), +2.4% vs $28.8B a year earlier, per its 10-K filed Feb 2026.
- Was Gilead profitable in FY2025?
- Yes: net income was $8.51B and operating income $10.0B in FY2025.
- What was Gilead's revenue in Q3 2026?
- $8.30B (+6.8% vs a year earlier), per its Form 10-Q filed Oct 30, 2026.